Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...
Gene editing in plants remains challenging, with the traditional non-homologous end-joining (cNHEJ) repair pathway often hindering precision. In this study, researchers advanced CRISPR-Cas-based gene ...
🛍️ Amazon Big Spring Sale: 100+ editor-approved deals worth buying right now 🛍️ By Amber Dance/Knowable Magazine Published Jan 26, 2024 3:00 PM EST Add Popular Science (opens in a new tab) Adding us ...
CRISPR’s promise of curing diseases hit a setback when researchers discovered that AZD7648, a molecule designed to improve precision, also caused catastrophic hidden damage to DNA. Instead of perfect ...
As avian influenza viruses continue to affect bird populations throughout the world, researchers have explored various means of controlling this pathogen. On Tuesday, scientists reported in the ...
In December 2020, the New England Journal of Medicine published a paper titled CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia, marking an exciting new chapter in the treatment of ...